4//SEC Filing
Claiborne Cary J 4
Accession 0001213900-21-064281
CIK 0001513525other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 9:23 PM ET
Size
5.4 KB
Accession
0001213900-21-064281
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Stock options
2021-12-07+130,000→ 130,000 totalExercise: $2.77From: 2021-12-07Exp: 2031-12-08→ Common stock (130,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001370930
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 9:23 PM ET
- Size
- 5.4 KB